Tissue-specific differentiation matrices and uses thereof

• US 9,617,511 B2
• Filed: 09/06/2011
• Issued: 04/11/2017
• Est. Priority Date: 09/07/2010
• Status: Active Grant

• Current Assignee: Board of Regents of the University of Texas System (University of Texas System)
• Original Assignee: Board of Regents of the University of Texas System (University of Texas System)
• Inventors: Chen, Xiao-Dong
• Primary Examiner(s): Claytor, Renee
• Assistant Examiner(s): Papciak, Sharon M
• Application Number:
  US13/821,288
• Publication Number:
  US 20130195814A1
• Time in Patent Office: 2,044 Days
• Field of Search: None
• CPC Class Codes: A61K 35/28 Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
• CPC Class Codes: A61K 35/34 Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes vascular smooth muscle A61K35/44
• CPC Class Codes: C12N 2501/06 Anti-neoplasic drugs, anti-retroviral drugs, e.g. azacytidine, cyclophosphamide
• CPC Class Codes: C12N 2501/115 Basic fibroblast growth factor (bFGF, FGF-2)
• CPC Class Codes: C12N 2502/1323 Adult fibroblasts
• CPC Class Codes: C12N 2533/52 Fibronectin; Laminin
• CPC Class Codes: C12N 2533/90 Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
• CPC Class Codes: C12N 5/0605 Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
• CPC Class Codes: C12N 5/0657 Cardiomyocytes; Heart cells
• CPC Class Codes: C12N 5/0662 Stem cells
• CPC Class Codes: C12N 5/0663 Bone marrow mesenchymal stem cells (BM-MSC)
• CPC Class Codes: C12N 5/0665 Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood

Abstract

In some aspects, this invention provides a method of making a bone marrow-derived tissue-specific stem cell proliferation, expansion, isolation and rejuvenation extracellular matrix. In other aspects, this invention provides a method of making a tissue-specific fibroblast-derived stem cell differentiation extracellular matrix. Also provided are methods of using such a cell-derived preservation or differentiation matrices to induce tissue-specific differentiation of pluripotent cells, repair damaged tissue, and treat a subject having a physiologic deficiency using the same.

Claims

1. A tissue-specific differentiation system comprising

a differentiation-inducing extracellular matrix generated ex vivo on a surface by culturing fibroblast cells on said surface, wherein the differentiation-inducing extracellular matrix is free of the fibroblast cells;

and

differentiated cells in contact with the differentiation-inducing extracellular matrix, wherein the differentiated cells are derived from isolated stem cells seeded onto the differentiation-inducing extracellular matrix and induced to undergo differentiation into differentiated cells of the same tissue type as the fibroblast cells b cultured on the differentiation-inducing extracellular extracellular matrix;

wherein the fibroblast cells and differentiated cells are both from one of the following tissue types;

neural tissue, epidermal tissue, dermal tissue, adipose tissue, cardiac tissue, kidney tissue, muscle tissue, liver tissue, cartilage tissue, pancreas tissue, tissue of the endometrium of uterus, umbilical cord tissue, or dental pulp tissue.

2. The tissue-specific differentiation system of claim 1, wherein the fibroblast cells are human or mouse fibroblast cells.

3. The tissue-specific differentiation system of claim 1, wherein the differentiation-inducing extracellular matrix is a 3D matrix.

4. The tissue-specific differentiation system of claim 1, wherein the differentiation-inducing extracellular matrix is free of feeder cells.

5. The method of claim 1, wherein the surface is a surface of a cell culture dish or plate.

6. The tissue-specific differentiation system of claim 1, wherein the isolated stem cells are from bone marrow, periosteum, trabecular bone, adipose tissue, synovium, skeletal muscle, deciduous teeth, fetal pancreas, lung, liver, amniotic fluid, umbilical cord blood and umbilical cord tissues.

7. The tissue-specific differentiation system of claim 1, wherein the isolated stem cells are naturally occurring stem cells or are engineered stern cells.

8. The tissue-specific differentiation system of claim 1, wherein the isolated stem cells are embryonic stem cells, mesenchymal stem cells or induced pluripotent stem cells.

9. A method of making a tissue-specific differentiation system comprising:

a) culturing fibroblast cells of a given tissue type ex vivo on a surface to produce a differentiation-inducing extracellular matrix;

b) removing the fibroblast cells from the differentiation-inducing extracellular matrix;

c) seeding isolated stem cells on the differentiation-inducing extracellular matrix; and

d) culturing the isolated stem cells on the differentiation-inducing extracellular matrix, thereby inducing the stem cells to differentiate into differentiated cells of the same tissue type as the fibroblast cells cultured in step (a);

wherein the fibroblast cells cultured in step and the differentiated cells produced in step (d) are both from one of the following tissue types;

neural tissue, epidermal tissue, dermal tissue, adipose tissue, cardiac tissue, kidney tissue, muscle tissue, liver tissue, cartilage tissue, pancreas tissue, tissue of the endometrium of uterus, umbilical cord tissue, or dental pulp tissue.

10. The method of claim 9, further comprising:

e) treating the differentiation-inducing extracellular matrix with DNase after removal of the fibroblast cells.

11. The method of claim 9, wherein the surface is coated with fibronectin.

12. The method of claim 11, wherein step (a) comprises culturing the fibroblast cells on the surface for 15 days.

13. The method of claim 12, wherein step (a) further comprises adding ascorbic acid to the surface during the final 8 days of culture.

14. The method of claim 9, wherein removing the fibroblast cells comprises incubating the differentiation-inducing extracellular matrix with Triton X-100 containing 20 mM NH₄OH in PBS.

15. The method of claim 9, wherein the fibroblast cells are of human or mouse origin.

16. The method of claim 9, wherein the differentiation-inducing extracellular matrix is a 3D matrix.

17. The method of claim 9, wherein the differentiation-inducing extracellular matrix is free of feeder cells.

18. The method of claim 9, wherein the differentiation-inducing extracellular matrix is free of target tissue-specific fibroblast cells.

19. The method of claim 9, wherein the surface is a surface of a cell culture dish or plate.

20. The method of claim 9, wherein the isolated stem cells are from bone marrow, periosteum, trabecular bone, adipose tissue, synovium, skeletal muscle, deciduous teeth, fetal pancreas, lung, liver, amniotic fluid, umbilical cord blood and umbilical cord tissues.

21. The method of claim 9, wherein the isolated stem cells are naturally occurring stem cells or are engineered stem cells.

22. The method of claim 9, wherein the isolated stem cells are embryonic stem cells, mesenchymal stem cells or induced pluripotent stem cells.

23. A method of inducing tissue-specific differentiation of isolated stem cells into a differentiated cell type comprising:

a) generating a first differentiation factor comprising a differentiation-inducing extracellular matrix by culturing fibroblast cells on a surface; and

b) contacting the isolated stem cells with the first differentiation factor, thereby inducing the stem cells to differentiate into the differentiated cell type,

wherein the differentiated cell type is of the same tissue type as the fibroblast cells, wherein the fibroblast cells have been removed from the differentiation-inducing extracellular matrix before contacting the isolated stem cells with the differentiation-inducing extracellular matrix, and wherein the fibroblast cells and differentiated cells are both from one of the following tissue types;

neural tissue, epidermal tissue, dermal tissue, adipose tissue, cardiac tissue, kidney tissue, muscle tissue, liver tissue, cartilage tissue, pancreas tissue, tissue of the endometrium of uterus, umbilical cord tissue, or dental pulp tissue.

24. The method of claim 23, wherein the differentiated cell type is a neuron, epithelial cell, dermal cell, adipocyte, cardiomyocyte, renal cell, myocyte, hepatocyte, chondrocyte, islet cell, endothelial cell, or dental pulp cells.

25. The method of claim 23, wherein the fibroblast cells are human or mouse fibroblast cells.

26. The method of claim 23, wherein the isolated stem cells are from bone marrow, periosteum, trabecular bone, adipose tissue, synovium, skeletal muscle, deciduous teeth, fetal pancreas, lung, liver, amniotic fluid, umbilical cord blood and umbilical cord tissues.

27. The method of claim 23, wherein the isolated stem cells are naturally occurring stem cells or are engineered stem cells.

28. The method of claim 23, wherein the isolated stern cells are embryonic stem cells, mesenchymal stem cells or induced pluripotent stem cells.

29. The method of claim 28, wherein the isolated stem cells are mesenchymal stem cells (MSCs) and are obtained by a method comprising:

i) contacting a MSC-containing sample with a cell-derived preservation matrix generated by human bone marrow cells; and

ii) isolating the MSCs from the cell-derived preservation extracellular matrix.

30. The method of claim 29, further comprising:

iii) expanding the isolated MSCs on a cell-derived preservation extracellular matrix generated by human bone marrow cells.

31. The method of claim 29, wherein the MSC-containing sample is from bone marrow, periosteum, trabecular bone, adipose tissue, synovium, skeletal muscle, deciduous teeth, fetal pancreas, lung, liver, amniotic fluid, umbilical cord blood and umbilical cord tissues.

32. The method of claim 23, wherein the method further comprises contacting the stern cells with a second differentiation factor.

33. The method of claim 32, wherein the differentiated cell type is cardiomyocyte and the second differentiation factor is bFGF and azacytidine.

34. The method of claim 23, wherein the differentiation-inducing extracellular matrix is a 3D matrix.

35. The method of claim 23, wherein the differentiation-inducing extracellular matrix is free of feeder cells.

36. The method of claim 23, wherein the differentiation-inducing extracellular matrix is free of fibroblast cells.

37. The method of claim 23, wherein the surface is a surface of a cell culture dish or plate.